199 related articles for article (PubMed ID: 20066167)
21. Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report.
Riste M; Davda P; Smith EG; Wyllie DH; Dedicoat M; Jog S; Laird S; Langman G; Jenkins N; Stevenson J; O'Shea MK
BMC Infect Dis; 2021 Feb; 21(1):151. PubMed ID: 33546627
[TBL] [Abstract][Full Text] [Related]
22. Vascular graft infections caused by
Arsuffi S; Cambianica A; Di Filippo E; Ripamonti D; Tebaldi A; Arosio MEG; Farina CF; Rizzi M
J Clin Tuberc Other Mycobact Dis; 2023 May; 31():100360. PubMed ID: 36941969
[TBL] [Abstract][Full Text] [Related]
23. Prosthetic joint infection due to Mycobacterium bovis 5-years after BCG-instillations.
Goedertier W; Sioen W
Acta Orthop Belg; 2020 Jun; 86(2):239-242. PubMed ID: 33418613
[TBL] [Abstract][Full Text] [Related]
24. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
[TBL] [Abstract][Full Text] [Related]
25. Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy.
Güven AT; Demiroğlu YZ; Koçer NE
Eur J Case Rep Intern Med; 2023; 10(9):004009. PubMed ID: 37680784
[TBL] [Abstract][Full Text] [Related]
26. The fate of bacillus Calmette-Guerin after intravesical instillation.
Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A
J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
[TBL] [Abstract][Full Text] [Related]
27. Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature.
Oladiran O; Nwosu I; Oladunjoye A; Oladunjoye O
J Community Hosp Intern Med Perspect; 2020 May; 10(2):168-170. PubMed ID: 32850058
[TBL] [Abstract][Full Text] [Related]
28. The possible influence of antibiotics on results of bacillus Calmette-Guérin intravesical therapy for superficial bladder cancer.
van der Meijden PM; van Klingeren B; Steerenberg PA; de Boer LC; de Jong WH; Debruyne FM
J Urol; 1991 Aug; 146(2):444-6. PubMed ID: 1856950
[TBL] [Abstract][Full Text] [Related]
29. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
Broekx S; Buelens E
Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
[TBL] [Abstract][Full Text] [Related]
30. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
Kudo T; Iwasa N; Maeda S; Mitarai S
Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
[TBL] [Abstract][Full Text] [Related]
31.
Meyer RK; Williams SJ; Lee TY
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100152. PubMed ID: 32140570
[TBL] [Abstract][Full Text] [Related]
32. A case of disseminated
Nishimura M; Okumura M; Takemasa T; Yoshiyama T; Tanaka Y; Saotome M; Ohta K
Respir Med Case Rep; 2023; 45():101902. PubMed ID: 37538979
[TBL] [Abstract][Full Text] [Related]
33. Bacillus Calmette-Guérin Packaged for Percutaneous Vaccination Can Be Safely Used for Intravesical Instillation in Patients with Urothelial Carcinoma of the Bladder.
Masic S; Srivastava A; Kloth D; Needleman R; Bloom E; Uzzo RN; Amoroso C; Lee R; Greenberg R; Smaldone M; Viterbo R; Joshi S; Chen DYT; Uzzo RG; Kutikov A
Urol Pract; 2020 Nov; 7(6):487-489. PubMed ID: 37287176
[TBL] [Abstract][Full Text] [Related]
34. Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin.
Samannodi M; Villavicencio A; Zhao A; Chavez V; Ericsson CD
IDCases; 2018; 14():e00465. PubMed ID: 30479960
[TBL] [Abstract][Full Text] [Related]
35. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
Parent ME; Richer M; Liang P
Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
[TBL] [Abstract][Full Text] [Related]
36. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
37. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
38. Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.
Hsu CW; Chiu YC; Hu HY; Fan YH; Hong SC; Cheng WM
BMC Urol; 2020 Jul; 20(1):91. PubMed ID: 32641099
[TBL] [Abstract][Full Text] [Related]
39. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
[TBL] [Abstract][Full Text] [Related]
40. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
Ratliff TL; Palmer JO; McGarr JA; Brown EJ
Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
